Provider review
Henry Meds review
Its own pages don't agree on which pharmacy category applies.
The tirzepatide page hedges between 503A and 503B; its Terms of Service state 503A alone — and neither names an actual pharmacy.
Transparency scorecard
2 of 4 disclosed openly
What Henry Meds discloses about itself, read from its own pages — not estimated.
Pharmacy named & regulated
Not disclosed
Does not name a pharmacy or state a regulatory category anywhere on its own site.
State coverage published
Not disclosed
Publishes no state coverage list — availability is something you learn during signup.
A real price is published
Disclosed
A real dollar figure is published on its own site, not estimated.
No hidden commitment trap
Disclosed
The advertised price is the ongoing price — no prepay or auto-refill required to unlock it.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
What it actually costs
What they advertise
Henry's own FAQ and treatment pages state plainly, "The price of GLP-1 medication varies by treatment plan and dosing, but starts at $179/month" — one monthly payment advertised to include "provider visit, medication and supplies, and ongoing care."
What you actually pay, month to month
There is no confirmed tirzepatide-specific number above that $179 floor: Henry's own pages state the $179 figure for its GLP-1 catalogue broadly (semaglutide, tirzepatide tablets, and more) rather than breaking tirzepatide out on its own, and no dose-tier price list is published anywhere we could find.
Money you will meet later
- Optional multi-month plans exist and may lower the effective monthly rate, but canceling one early for a non-medical reason means you "may be required to pay out the rest of your balance," per Henry's own FAQ.
Checked live on Henry Meds's own site at https://henrymeds.com/faq in August 2026. Prices change without notice — confirm before you buy. Every figure here was read off Henry Meds's own public pages on the date shown, not from a third-party comparison table.
The bottom line
Henry Meds sells compounded oral tirzepatide tablets with one advertised monthly price, "starts at $179/month," covering the provider visit, medication, and supplies together. What we could not reconcile: its own tirzepatide page says compounding happens in "a 503(A) Compounding Pharmacy or 503(B) Outsourcing Facility," while its own Terms of Service state, separately, that medications "are prepared in accordance with Section 503A" — two pages on the same site giving two different answers, and neither naming an actual pharmacy. The default plan is month-to-month with no long-term contract, but an optional multi-month plan carries a real early-cancellation cost its FAQ discloses only in the fine print.
Henry Meds appears on our tirzepatide provider ranking. Nothing on this page is a performance claim.
Who it is for, and who it is not
A good fit if
- You want a single advertised monthly figure that bundles the provider visit, medication, and supplies together, per Henry's own site.
- You want the option to cancel a month-to-month plan any time, with no long-term contract by default.
- You want a provider that states its FDA-approval status plainly rather than leaving it implied.
Look elsewhere if
- You want a provider whose own site consistently names one regulatory category for its pharmacy — Henry's tirzepatide page and its Terms of Service state two different things.
- You want to see a tirzepatide-specific dollar figure before signing up — the published $179 floor covers Henry's whole GLP-1 catalogue, not tirzepatide alone.
- You are considering a multi-month plan for the savings — read the cancellation terms first, since an early exit for a non-medical reason can mean paying out the remaining balance.
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what Henry Meds bundles in, and what it does not.
Clinician consult
A licensed healthcare provider visit is included in the monthly…
price, per Henry's own site — described only as "a licensed healthcare provider," no specialty or credential named beyond that.
Bloodwork / labs
Not stated on site
— no bloodwork requirement or lab-inclusion policy is published.
Follow-ups and dose changes
"Ongoing care" is advertised as part of the plan price; no…
specific follow-up cadence is itemized.
Human support
No dietitian, nurse, or structured coaching program is named on…
any page we checked (FAQ, values, how-it-works) — support is described only as a provider visit plus messaging through the patient portal.
Injection supplies
"Medication and supplies" are advertised as included in the…
monthly price; nothing further is itemized.
Shipping
Described as mailed "straight to your door"; Henry's own FAQ…
separately notes California orders may see "longer fulfillment times because of additional compound testing requirements." No shipping fee is stated.
Who fills it, and who's watching
The pharmacy
Not named. Henry's own tirzepatide-tablets and GLP-1 pages both describe medication as compounded "in a 503(A) Compounding Pharmacy or 503(B) Outsourcing Facility" — hedging between the two rather than naming one — while its separate Terms of Service state medications "are prepared in accordance with Section 503A of the Federal Food, Drug, and Cosmetic Act." The two pages do not agree, and neither names an actual pharmacy.
Oversight
A licensed healthcare provider visit is included in the monthly price, per Henry's own site — described only as "a licensed healthcare provider," no specialty or credential named beyond that. "Ongoing care" is advertised as part of the plan price; no specific follow-up cadence is itemized.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not.
Where you can get it
Not published. Henry's own FAQ and Terms of Service both say only that a customer must "Live or have an address in one of the states we support," with no list given; the Terms of Service adds that availability "may change...at any time." California is flagged only for slower fulfillment, not exclusion.
The honest cons
The part they would rather you skipped
Henry Meds' own pages contradict each other on the one fact this site is built to check: its tirzepatide page hedges between "a 503(A) Compounding Pharmacy or 503(B) Outsourcing Facility," while its Terms of Service state "Section 503A" alone — and if you sign up for an optional multi-month plan and need to stop for a non-medical reason, its own FAQ says you "may be required to pay out the rest of your balance."
- Its own pages disagree on which regulatory category applies to its compounding pharmacy, and neither names an actual pharmacy
- "Starts at $179/month" is stated for its whole GLP-1 catalogue, not confirmed as tirzepatide's own number, and no dose-tier breakdown is published
- An optional multi-month plan carries an early-cancellation balance-payout risk that its default month-to-month plan does not — read the FAQ before choosing a plan length
None of this is unique to Henry Meds — the whole category shares it.
How it compares
The providers we rank on our tirzepatide provider ranking — the most specific board Henry Meds sits on — in the order that board ranks them.
- FOFoundStates a 503A category for its pharmacy — but the $99 floor needs a multi-month prepay.
- Precision TelemedThe only provider on either board that names an actual compounding pharmacy.

- CoreAge RxA low advertised floor on both boards, with no named pharmacy and no ceiling.

- yourEraA single-page price list, but no pharmacy name and no sermorelin at all.

- PLPlexusDxPriciest starting-price seller; the only one admitting it's not FDA-approved.
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect Henry Meds's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Henry Meds's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.